Haemonetics | HAE - Aktuelle Verpflichtungen

Aktienkurs
57.60
Täglich Wechseln
0.75 1.32%
Monatlich
-4.33%
Jährlich
-13.93%
Q2 Prognose
55.16




Aktuelle Verpflichtungen Veränderung Datum
Avanos Medical USD 131.2M 34M 2026-03
Baxter International USD 3.69B 723M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Cerus USD 100.8M 12.37M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Fresenius EUR 8.38B 1.18B 2025-12
Fresenius Medical Care EUR 6.73B 484.42M 2026-03
Globus Medical USD 482.46M 16.04M 2026-03
Haemonetics USD 282.6M 257.27M 2026-03
ICU Medical USD 517.9M 19.04M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
Masimo USD 325.4M 46.2M 2026-03
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 216.87M 22.89M 2026-03
Neogen USD 150.6M 3.55M 2025-12
OraSure Technologies USD 44.08M 4.29M 2026-03
Plus Therapeutics USD 7.96M 4.36M 2026-03
Quidel USD 962.4M 3.7M 2026-03
ResMed USD 1.35B 103.1M 2026-03
STAAR Surgical USD 60.99M 7.51M 2026-03
Steris USD 1.14B 222.7M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Surmodics USD 19.44M 1.1M 2025-06
Teleflex USD 728.05M 33.98M 2026-03
Terumo JPY 540.73B 1.03B 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
US Physical Therapy USD 117.3M 21.74M 2026-03
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03